You turn to us for voices you won't hear anywhere else.

Sign up for Democracy Now!'s Daily Digest to get our latest headlines and stories delivered to your inbox every day.

Communities of Color Hit Hardest by COVID Less Likely to Receive Antiviral Drugs

HeadlineOct 28, 2022

The U.S. Centers for Disease Control and Prevention is warning communities of color are far less likely to benefit from potentially life-saving treatments for COVID-19. A CDC study released Thursday found African American and Latinx patients received the antiviral drug Paxlovid more than 30% less often than white patients — even though people of color in the U.S. are about twice as likely to be hospitalized with COVID. This comes as U.S. coronavirus hospitalizations have begun to increase for the first time since July.

The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

Non-commercial news needs your support

We rely on contributions from our viewers and listeners to do our work.
Please do your part today.
Make a donation